Published October 15, 2019
| Version v1
Patent
Open
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
Files
US10441596.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:b44b5ea345d46b9fcb06411761f83d81
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10441596 B2
- Patent application number
- US 201715448827 A
- Other
- oai:uchicago.tind.io:6985
Dates
- Patent filed
-
2017-03-03